G&E Herbal Biotechnology Co., Ltd. - Laporan Laba Rugi (TTM)

G&E Herbal Biotechnology Co., Ltd.
TW ˙ TPEX
NT$ 58.40 ↑0.50 (0.86%)
2024-10-25
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi G&E Herbal Biotechnology Co., Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 24 28 32 31 29 25 24 28 40 65 98 135 163 181 196 211 231 249 274 294
Change (%) 18.52 14.88 -4.61 -7.11 -14.49 -3.98 17.06 43.66 62.83 51.88 37.54 20.54 11.53 8.07 7.68 9.33 7.88 9.93 7.48
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 18 16 19 17 15 15 16 20 23 25 29 31 34 37 38 40 42 44 46 46
Change (%) -8.66 15.55 -8.75 -11.96 -0.71 5.33 24.99 15.79 10.84 12.93 9.69 8.80 8.29 2.34 7.14 3.91 4.04 4.49 0.62
% of Revenue 74.54 57.44 57.78 55.27 52.39 60.83 66.72 71.24 57.42 39.09 29.06 23.18 20.92 20.31 19.24 19.14 18.19 17.54 16.68 15.61
Gross Operating Profit 6 12 14 14 14 10 8 8 17 39 70 104 129 145 158 171 189 205 228 248
Change (%) 98.12 13.98 1.06 -1.13 -29.65 -18.42 1.15 112.72 132.95 76.87 48.95 24.08 12.39 9.53 7.81 10.61 8.74 11.09 8.86
% of Revenue 25.46 42.56 42.22 44.73 47.61 39.17 33.28 28.76 42.58 60.91 70.94 76.82 79.08 79.69 80.76 80.86 81.81 82.46 83.32 84.39
SG&A 15 15 16 16 16 17 16 18 12 19 23 30 23 39 40 42 64 50 58 65
Change (%) -0.28 7.44 -2.23 3.67 3.53 -2.56 8.84 -34.40 68.20 20.12 26.66 -21.08 68.01 2.41 3.61 53.27 -21.22 14.66 11.98
% of Revenue 62.17 52.31 48.92 50.14 55.96 67.75 68.75 63.93 29.19 30.15 23.85 21.96 14.38 21.66 20.53 19.75 27.69 20.22 21.09 21.97
R&D 13 13 13 13 12 13 12 13 13 14 17 18 23 25 32 36 35 35 35 33
Change (%) 1.52 3.38 -3.72 -7.90 7.50 -0.37 2.99 2.19 9.42 19.55 7.55 23.02 8.10 30.99 10.68 -1.29 0.37 -2.11 -5.30
% of Revenue 52.62 45.07 40.56 40.93 40.59 51.03 52.95 46.59 33.14 22.27 17.53 13.71 13.99 13.56 16.43 16.89 15.25 14.19 12.64 11.13
OpEx 45 44 48 45 43 44 44 50 53 59 69 79 92 101 110 118 123 129 138 143
Change (%) -3.08 9.26 -5.20 -5.47 3.12 0.73 12.92 6.52 10.56 16.91 14.90 15.86 9.51 9.36 6.89 4.71 4.91 6.65 3.89
% of Revenue 189.32 154.81 147.25 146.34 148.93 179.61 188.42 181.75 134.77 91.51 70.44 58.85 56.56 55.53 56.20 55.78 53.43 51.96 50.40 48.72
Operating Income -21 -15 -15 -14 -14 -20 -21 -23 -14 5 29 56 71 81 86 93 108 120 136 151
Change (%) -27.27 -0.98 -6.45 -1.92 39.12 6.65 8.24 -38.90 -139.77 428.73 91.49 27.23 14.17 6.45 8.71 15.15 11.29 13.48 11.14
% of Revenue -89.32 -54.81 -47.25 -46.34 -48.93 -79.61 -88.42 -81.75 -34.77 8.49 29.56 41.15 43.44 44.47 43.80 44.22 46.57 48.04 49.60 51.28
Interest Expense -0 -0 -0 -0 -0 -0 -0
Change (%) 250.00 64.29 47.83 20.59 -2.44 -2.50
% of Revenue -0.00 -0.01 -0.01 -0.01 -0.02 -0.01 -0.01
Net Income -16 -14 -14 -13 -13 -20 -22 -20 -11 7 27 47 64 72 77 84 91 102 119 135
Change (%) -8.27 -4.21 -3.45 -2.12 53.58 8.44 -8.03 -44.51 -167.08 271.97 71.37 35.04 13.95 6.33 8.89 8.61 12.11 16.55 13.16
% of Revenue -65.46 -50.66 -42.24 -42.76 -45.06 -80.92 -91.39 -71.80 -27.73 11.42 27.98 34.86 39.06 39.90 39.26 39.70 39.44 40.98 43.45 45.74

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista